- Home
- CYH vs ORGO Comparison
CYH vs ORGO Comparison
Compare CYH & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- ORGO
- Stock Information
- Founded
- CYH 1985
- ORGO 1985
- Country
- CYH United States
- ORGO United States
- Employees
- CYH N/A
- ORGO N/A
- Industry
- CYH Hospital/Nursing Management
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CYH Health Care
- ORGO Health Care
- Exchange
- CYH Nasdaq
- ORGO Nasdaq
- Market Cap
- CYH 482.7M
- ORGO 465.6M
- IPO Year
- CYH 1991
- ORGO N/A
- Fundamental
- Price
- CYH $2.80
- ORGO $4.78
- Analyst Decision
- CYH Hold
- ORGO Buy
- Analyst Count
- CYH 9
- ORGO 2
- Target Price
- CYH $4.19
- ORGO $6.50
- AVG Volume (30 Days)
- CYH 3.4M
- ORGO 995.1K
- Earning Date
- CYH 07-23-2025
- ORGO 08-07-2025
- Dividend Yield
- CYH N/A
- ORGO N/A
- EPS Growth
- CYH N/A
- ORGO N/A
- EPS
- CYH N/A
- ORGO N/A
- Revenue
- CYH $12,647,000,000.00
- ORGO $458,760,000.00
- Revenue This Year
- CYH N/A
- ORGO $1.10
- Revenue Next Year
- CYH $3.16
- ORGO $9.93
- P/E Ratio
- CYH N/A
- ORGO N/A
- Revenue Growth
- CYH 0.81
- ORGO 5.35
- 52 Week Low
- CYH $2.24
- ORGO $2.28
- 52 Week High
- CYH $6.29
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- CYH 31.21
- ORGO 60.81
- Support Level
- CYH $2.68
- ORGO $4.30
- Resistance Level
- CYH $3.97
- ORGO $5.02
- Average True Range (ATR)
- CYH 0.17
- ORGO 0.26
- MACD
- CYH -0.07
- ORGO 0.02
- Stochastic Oscillator
- CYH 12.71
- ORGO 73.15
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.